FDA approves Bristol Myers Squibb's schizophrenia drug
WEB12 hours ago · The Food and Drug Administration approved Bristol Myers Squibb’s highly anticipated schizophrenia drug, the first novel type of treatment for the debilitating, chronic mental disorder in more ...
Bristol Myers Squibb - U.S. Food and Drug Administration …
WEB1 day ago · PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults. 1 COBENFY represents the first new class of medicine in several decades and introduces a fundamentally new approach to treating ...
U.S. Food and Drug Administration Approves Bristol Myers …
WEB10 hours ago · About Bristol Myers Squibb. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over ...
Bristol-Myers Squibb’s Cobenfy Launch Spurs ‘Buy’ Rating Amid …
WEB3 hours ago · Founded in 1933, New York-based Bristol-Myers Squibb Co. is a global pharmaceutical company, which engages in the development, licensing, manufacturing, distribution, and sale of biopharmaceutical ...
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
WEB2 hours ago · Bristol-Myers Squibb shares rose in premarket trade on Friday after the U.S. Food and Drug Administration approved a schizophrenia drug. Bristol-Myers shares BMY jumped 6% to a five-month high in ...
Bristol Myers (BMY) Gets US Nod for First New Schizophrenia Drug …
WEB12 hours ago · September 26, 2024 at 6:53 PM EDT. Bristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh avenue of treatment for millions with ...
Bristol Myers Squibb - News
WEBSep 9, 2024 · Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms
Bristol Myers Squibb - Bristol Myers Squibb Completes Acquisition …
WEBMar 18, 2024 · PRINCETON, N.J.-- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. (“Karuna”).
Sell Rating on Bristol-Myers Squibb Amid Competitive Pressures …
WEB5 hours ago · Founded in 1933, New York-based Bristol-Myers Squibb Co. is a global pharmaceutical company, which engages in the development, licensing, manufacturing, distribution, and sale of biopharmaceutical ...
US FDA approves Bristol Myers' schizophrenia drug
WEB12 hours ago · September 26, 2024 at 6:50 PM. (Reuters) -The U.S. FDA approved Bristol Myers Squibb's schizophrenia drug on Thursday, providing patients with a treatment option that reduces symptoms of the ...
Skip to content